相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses
Elahe Aleebrahim-Dehkordi et al.
TRANSPLANT IMMUNOLOGY (2022)
Bringing social context into global biomedical HIV cure-related research: An urgent call to action
Annie Miall et al.
JOURNAL OF VIRUS ERADICATION (2022)
Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates
Peng Xiao et al.
FRONTIERS IN IMMUNOLOGY (2021)
The potential of adenoviral vaccine vectors with altered antigen presentation capabilities
Lasse Neukirch et al.
EXPERT REVIEW OF VACCINES (2020)
Herpes simplex virus: global infection prevalence and incidence estimates, 2016
Charlotte James et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption
Donn J. Colby et al.
NATURE MEDICINE (2020)
Factors That Influence the Immune Response to Vaccination
Petra Zimmermann et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Updated Studies on the Development of HIV Therapeutic Vaccine
Mona Sadat Larijani et al.
CURRENT HIV RESEARCH (2019)
Novel prime-boost vaccine strategies against HIV-1
Jean-Louis Excler et al.
EXPERT REVIEW OF VACCINES (2019)
Analysis of Select Herpes Simplex Virus 1 (HSV-1) Proteins for Restriction of Human Immunodeficiency Virus Type 1 (HIV-1): HSV-1 gM Protein Potently Restricts HIV-1 by Preventing Intracellular Transport and Processing of Env gp160
Sachith Polpitiya Arachchige et al.
JOURNAL OF VIROLOGY (2018)
Immunization by Replication-Competent Controlled Herpesvirus Vectors
David C. Bloom et al.
JOURNAL OF VIROLOGY (2018)
Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia
Gizachew Ayele et al.
BMC IMMUNOLOGY (2018)
HIV-1 Immunogen: an overview of almost 30 years of clinical testing of a candidate therapeutic vaccine
Gina M. Graziani et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
HSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5a
H. Kanda et al.
GENE THERAPY (2016)
Expression and immunogenicity of recombinant glycoprotein D of herpes simplex virus 1 in Drosophila S2 cells
Hongyan Mao et al.
PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY (2016)
The combination of Pleurotus ferulae water extract and CpG-ODN enhances the immune responses and antitumor efficacy of HPV peptides pulsed dendritic cell-based vaccine
Jinyu Li et al.
VACCINE (2016)
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection
Francesco Nicoli et al.
VACCINE (2016)
Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine
Aurelio Cafaro et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Innate immunity against HIV-1 infection
Marcus Altfeld et al.
NATURE IMMUNOLOGY (2015)
Effects of different promoters on the virulence and immunogenicity of a HIV-1 Env-expressing recombinant vaccinia vaccine
Mao Isshiki et al.
VACCINE (2014)
The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination
Kristin Hollister et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Past, present and future: 30 years of HIV research
Francoise Barre-Sinoussi et al.
NATURE REVIEWS MICROBIOLOGY (2013)
HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component
Lifei Yang et al.
JOURNAL OF VIROLOGY (2012)
Superior Neutralizing Antibody Response and Protection in Mice Vaccinated with Heterologous DNA Prime and Virus Like Particle Boost against HPAI H5N1 Virus
Heng Ding et al.
PLOS ONE (2011)
Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
Sunil K. Geevarghese et al.
HUMAN GENE THERAPY (2010)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic engineering of a modified herpes simplex virus 1 vaccine vector
XueQiao Liu et al.
VACCINE (2009)
HIV molecular epidemiology: transmission and adaptation to human populations
Zenda Woodman et al.
CURRENT OPINION IN HIV AND AIDS (2009)
HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime
Cindy M. P. Duke et al.
VACCINE (2007)
HIV-189.6Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice
Scott D. Parker et al.
VACCINE (2007)
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag
Kathlyn Santos et al.
VACCINE (2007)
Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus
Amitinder Kaur et al.
VIROLOGY (2007)
Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector
Daisuke Watanabe et al.
VIROLOGY (2007)
Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases
Toshihiko Kuroda et al.
BMC BIOTECHNOLOGY (2006)
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity
H Lauterbach et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 env and SIV Gag proteins: Comparison of intranasal and intramuscular vaccination routes
MA Egan et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
S Kostense et al.
AIDS (2004)
HIV vaccine development: Lessons from the past and promise for the future
P Spearman
CURRENT HIV RESEARCH (2003)
FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review
EW Uhl et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2002)
Evaluation in rhesus macaques of Tat and Rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08
B Verrier et al.
DNA AND CELL BIOLOGY (2002)
Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type I Gag and Env proteins
K Haglund et al.
JOURNAL OF VIROLOGY (2002)
Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses
PK Hocknell et al.
JOURNAL OF VIROLOGY (2002)
Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity
MA Brockman et al.
JOURNAL OF VIROLOGY (2002)
Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus
RJ Wong et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2001)
General strategy for constructing large HSV-1 plasmid vectors that co-express multiple genes
XD Wang et al.
BIOTECHNIQUES (2001)
Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity
M Kruse et al.
JOURNAL OF VIROLOGY (2000)
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus
CG Murphy et al.
JOURNAL OF VIROLOGY (2000)
分享论文
